Neurology
NPI
1770630212
Specialty
Neurology
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Medicare paid, 2024
$161K
19,859 services
Medicare patients, 2024
236
Average age 72
Drug cost, 2024
$665K
3,678 prescriptions
Company payments, 2025
$2,251
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence Robbins was code J0585 (injection, onabotulinumtoxina, 1 unit), 19,077 times for 51 patients. In total Lawrence Robbins billed 19,859 services in 6 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: -.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 19,077 | 51 | $4.65 | $89K |
| 99214 Office E&M - Established | Office | 623 | 202 | $85.40 | $53K |
| 64615 Musculoskeletal | Office | 147 | 51 | $121.74 | $18K |
By year: 2022 $155K for 17,502 services; 2023 $167K for 18,581 services; 2024 $161K for 19,859 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence Robbins prescribed most often to Medicare patients was Sumatriptan Succinate, with 259 prescriptions and refills. In total Lawrence Robbins wrote 3,678 Medicare prescriptions that cost $665K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sumatriptan Succinate Generic | 259 | 377 | 64 | $8,815 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 226 | 234 | 36 | $7,255 |
| Alprazolam Generic | 141 | 141 | 30 | $1,112 |
| Gabapentin Generic | 134 | 219 | 31 | $2,515 |
| Clonazepam Generic | 121 | 152 | 19 | $549 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 108 | 108 | 30 | $1,824 |
| Naratriptan Hcl Generic | 97 | 115 | 21 | $6,308 |
| Zolpidem Tartrate Generic | 84 | 105 | 15 | $616 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 84 | 84 | Under 11 | $1,154 |
| Nurtec Odt Rimegepant Sulfate | 82 | 87 | 19 | $141K |
| Sertraline Hcl Generic | 78 | 206 | 18 | $832 |
| Zolmitriptan Generic | 74 | 84 | Under 11 | $32K |
| Amitriptyline Hcl Generic | 69 | 189 | 16 | $1,348 |
| Qulipta Atogepant | 67 | 78 | 15 | $84K |
| Tizanidine Hcl Generic | 66 | 103 | 15 | $499 |
Brand drugs: 485 claims; generic drugs: 3,193 claims; opioid claims: 311.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence Robbins $2,251 ($2,251 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $544.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $544 |
| Pfizer Inc. PFE | 29 | $543 |
| Lundbeck LLC | 21 | $428 |
| Axsome Therapeutics, Inc. AXSM | 11 | $254 |
| Tonix Medicines, Inc. | 8 | $148 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $69.36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $57.33 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $43.52 |
| Lilly USA, LLC LLY | 2 | $36.18 |
| Merz Pharmaceuticals, LLC | 1 | $29.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.